Adhera names new chief

|About: Adhera Therapeutics, Inc. (ATRX)|By:, SA News Editor

Thinly traded specialty pharmaceutical company Adhera Therapeutics (OTCQB:ATRX) appoints Nancy Phelan as the new Chief Executive Officer of the Company

She has served as a member of the Board of Directors since October 2018.

In connection with the appointment of Ms. Phelan as CEO, Robert Moscato, Jr. resigned from such position, as well as board member, effective immediately.

Subscribe for full text news in your inbox